A Retrospective Study of Prognostic Factors and Survival of Breast Cancer Patients with Brain Metastesis

Launched by ASSIUT UNIVERSITY · Dec 4, 2024

Keywords

ClinConnect Summary

This clinical trial is looking at breast cancer patients who have developed brain metastases, which means their cancer has spread to the brain. The study aims to understand how common this condition is, identify factors that might increase the risk of brain metastases, and evaluate how different treatments can affect survival after this happens. By gathering this information, researchers hope to find ways to better support patients who are at higher risk and improve their treatment options.

To be eligible for this study, participants need to be over 18 and have a confirmed diagnosis of breast cancer. They also must have documented evidence of brain metastases through imaging tests like a CT scan or MRI and should have been monitored for at least six months. Unfortunately, patients with certain other conditions, such as a different type of cancer or incomplete medical records, will not be able to participate. This study is not yet recruiting, so there will be more information available as it progresses. Overall, this research could provide valuable insights for future treatment and care for breast cancer patients facing brain metastases.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • -Age \>18
• • Histological proven breast cancer
• • Radiological documentation of BM by computed tomography (CT) OR magnetic resonance imaging (MRI)
• • Patients who had been followed up for at least 6 months.
• Exclusion Criteria:
• • -Not histologically proven Breast cancer
• • Patient without full medical data
• • Those with previous or concurrent diagnosis of second primary malignancy
• • Patients with leptomeningeal or dural metastases without co-existent parenchymal metastatic lesions